Evidence map›Paper›PMID 37308910›Full record

ArticleOrphanet journal of rare diseases2023

Expanding genotype-phenotype correlations in FOXG1 syndrome: results from a patient registry.

Elise Brimble, Kathryn G Reyes, Kopika Kuhathaas, Orrin Devinsky, Maura R Z Ruzhnikov, Xilma R Ortiz-Gonzalez, Ingrid Scheffer, Nadia Bahi-Buisson, Heather Olson, FOXG1 Research Foundation

Open access · goldAbstract read
In one paragraph

Article in Orphanet journal of rare diseases, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
6.3field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Developmental trajectories of GABAergic cortical interneurons are sequentially modulated by dynamicProceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 9 institutions in 3 countries.

Elise BrimbleInvitae, San Francisco, CA, USA. elli.brimble@invitae.com.ORCID 0000-0002-7238-7342
Kathryn G ReyesCedars Sinai, Los Angeles, CA, USA.
Kopika KuhathaasMGH Institute of Health Professions, Boston, MA, USA.
Orrin DevinskyNYU Langone Health, New York, NY, USA.
Maura R Z RuzhnikovU.S. Food and Drug Administration, Silver Spring, MD, USA.
Xilma R Ortiz-GonzalezChildren's Hospital of Philadelphia, Philadelphia, PA, USA.
Ingrid SchefferUniversity of Melbourne, Melbourne, Australia.
Nadia Bahi-BuissonParis Descartes University/Neckers Hospital, Paris, France.
Heather OlsonBoston Children's Hospital, Boston, MA, USA.
FOXG1 Research Foundation
Boston Children's Hospital · USCedars-Sinai Medical Center · USChildren's Hospital of Philadelphia · USDélégation Paris 5 · FRInvitae (United States) · USMGH Institute of Health Professions · USNYU Langone Health · USThe University of Melbourne · AUUnited States Food and Drug Administration · US

Funding

Genetic Analysis and Manipulation Core (GAEC)P50HD105351 · NICHD · BOSTON CHILDREN'S HOSPITAL · PI Hisashi Umemori · 2021 to 2026
$9.4M
Diagnosis and Genotype-Phenotype Correlations in Early Life Epilepsy and CDKL5 DisorderK23NS107646 · NINDS · BOSTON CHILDREN'S HOSPITAL · PI OLSON, HEATHER ELISA · 2018 to 2023
$1.2M
NICHD NIH HHS P50 HD105351NINDS NIH HHS K23 NS107646
6 · The paper itself

Abstract

backgroundWe refine the clinical spectrum of FOXG1 syndrome and expand genotype-phenotype correlations through evaluation of 122 individuals enrolled in an international patient registry.

methodsThe FOXG1 syndrome online patient registry allows for remote collection of caregiver-reported outcomes. Inclusion required documentation of a (likely) pathogenic variant in FOXG1. Caregivers were administered a questionnaire to evaluate clinical severity of core features of FOXG1 syndrome. Genotype-phenotype correlations were determined using nonparametric analyses.

resultsWe studied 122 registry participants with FOXG1 syndrome, aged < 12 months to 24 years. Caregivers described delayed or absent developmental milestone attainment, seizures (61%), and movement disorders (58%). Participants harbouring a missense variant had a milder phenotype. Compared to individuals with gene deletions (0%) or nonsense variants (20%), missense variants were associated with more frequent attainment of sitting (73%). Further, individuals with missense variants (41%) achieved independent walking more frequently than those with gene deletions (0%) or frameshift variants (6%). Presence of epilepsy also varied by genotype and was significantly more common in those with gene deletions (81%) compared to missense variants (47%). Individuals with gene deletions were more likely to have higher seizure burden than other genotypes with 53% reporting daily seizures, even at best control. We also observed that truncations preserving the forkhead DNA binding domain were associated with better developmental outcomes.

conclusionWe refine the phenotypic spectrum of neurodevelopmental features associated with FOXG1 syndrome. We strengthen genotype-driven outcomes, where missense variants are associated with a milder clinical course.

Indexed as

Rett SyndromeForkhead Transcription FactorsFrameshift MutationGenotypeHumansNerve Tissue ProteinsRegistriesSeizuresForkhead Transcription FactorsFOXG1 protein, humanNerve Tissue ProteinsEpilepsyGenotype–phenotype associationMovement DisorderPatient registryRare neurological diseases

Identifiers

PMID37308910
PMCPMC10262363
OpenAlexW4380368597

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.